E. Amelina

734 total citations
77 papers, 321 citations indexed

About

E. Amelina is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Emergency Medical Services. According to data from OpenAlex, E. Amelina has authored 77 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Pulmonary and Respiratory Medicine, 12 papers in Molecular Biology and 12 papers in Emergency Medical Services. Recurrent topics in E. Amelina's work include Cystic Fibrosis Research Advances (60 papers), Neonatal Respiratory Health Research (24 papers) and Pediatric health and respiratory diseases (12 papers). E. Amelina is often cited by papers focused on Cystic Fibrosis Research Advances (60 papers), Neonatal Respiratory Health Research (24 papers) and Pediatric health and respiratory diseases (12 papers). E. Amelina collaborates with scholars based in Russia, France and Kazakhstan. E. Amelina's co-authors include А. Г. Чучалин, Federico Bianco, Olga L. Voronina, Marina S. Kunda, Н. Н. Рыжова, Gintsburg Al, Ekaterina I. Aksenova, N. Kashirskaya, Svetlana Smirnikhina and А. В. Лавров and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

E. Amelina

57 papers receiving 309 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Amelina Russia 10 213 93 41 35 26 77 321
Amir Akhavan Rezayat Iran 8 138 0.6× 95 1.0× 44 1.1× 13 0.4× 22 0.8× 14 292
Annette Sauer‐Heilborn Germany 10 175 0.8× 85 0.9× 25 0.6× 17 0.5× 7 0.3× 15 340
Nicole Mayer‐Hamblett United States 8 313 1.5× 80 0.9× 89 2.2× 18 0.5× 11 0.4× 16 366
Benjamin R. Macadangdang United States 5 57 0.3× 139 1.5× 57 1.4× 20 0.6× 40 1.5× 6 290
Gökçen Dilşa Tuğcu Türkiye 7 119 0.6× 25 0.3× 21 0.5× 10 0.3× 24 0.9× 31 180
Samuel Montgomery Australia 7 300 1.4× 70 0.8× 63 1.5× 42 1.2× 7 0.3× 15 395
Howard Todd United Kingdom 8 151 0.7× 98 1.1× 195 4.8× 33 0.9× 31 1.2× 9 439
H. G. de Vries Netherlands 7 64 0.3× 75 0.8× 48 1.2× 14 0.4× 34 1.3× 9 274
Spyridon Megremis Greece 11 116 0.5× 80 0.9× 162 4.0× 42 1.2× 12 0.5× 25 340
Adelina Amorim Portugal 11 155 0.7× 17 0.2× 54 1.3× 12 0.3× 9 0.3× 39 236

Countries citing papers authored by E. Amelina

Since Specialization
Citations

This map shows the geographic impact of E. Amelina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Amelina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Amelina more than expected).

Fields of papers citing papers by E. Amelina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Amelina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Amelina. The network helps show where E. Amelina may publish in the future.

Co-authorship network of co-authors of E. Amelina

This figure shows the co-authorship network connecting the top 25 collaborators of E. Amelina. A scholar is included among the top collaborators of E. Amelina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Amelina. E. Amelina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Авдеев, С. Н., et al.. (2025). Pathogenetic treatment of cystic fibrosis: expanding access to drugs. Лечащий врач.
3.
4.
Amelina, E., et al.. (2024). THE FIRST RESULTS OF TARGETED THERAPY IN CHILDREN WITH CYSTIC FIBROSIS IN KAZAKHSTAN. 7–14. 1 indexed citations
5.
Amelina, E., et al.. (2024). P137 Clinical characteristics of adult cystic fibrosis (CF) patients in Kazakhstan. Journal of Cystic Fibrosis. 23. S127–S128. 1 indexed citations
6.
Amelina, E., et al.. (2024). Сhronic rhinosinusitis in adult patients with cystic fibrosis receiving CFTR modulators. PULMONOLOGIYA. 34(2). 257–263.
7.
Demchenko, Anna, Т. Б. Бухарова, Dmitry Goldshtein, et al.. (2023). Airway and Lung Organoids from Human-Induced Pluripotent Stem Cells Can Be Used to Assess CFTR Conductance. International Journal of Molecular Sciences. 24(7). 6293–6293. 10 indexed citations
8.
9.
Kondratyeva, E., Т. Б. Бухарова, Mikhail Skoblov, et al.. (2021). Health Characteristics of Patients with Cystic Fibrosis whose Genotype Includes a Variant of the Nucleotide Sequence c.3140-16T>A and Functional Analysis of this Variant. Genes. 12(6). 837–837. 9 indexed citations
10.
11.
Smirnikhina, Svetlana, et al.. (2020). P.F508del editing in cells from cystic fibrosis patients. PLoS ONE. 15(11). e0242094–e0242094. 15 indexed citations
12.
Voronina, Olga L., Н. Н. Рыжова, Marina S. Kunda, et al.. (2019). MAJOR TENDENCIES IN BURKHOLDERIA DIVERSITY CHANGES, INFECTING RUSSIAN PATIENTS WITH CYSTIC FIBROSIS. Siberian medical review. 80–88. 1 indexed citations
13.
Yu, Charles, et al.. (2017). Use of the MALDI Biotyper system and the microbiological diagnosis algorithm for identification of non-fermenting bacteria isolated from respiratory tract in cystic fibrosis patients. SHILAP Revista de lepidopterología. 1 indexed citations
14.
Shaginyan, I.A., M.Y. Chernukha, E. Kondratyeva, et al.. (2017). 162 Phenotypic and genotypic variability of pathogens of chronic lung infection in cystic fibrosis patients. Journal of Cystic Fibrosis. 16. S107–S108. 1 indexed citations
15.
Amelina, E., et al.. (2014). CYSTIC FIBROSIS PHENOTYPES IN ADULT PATIENTS CARRYING 3849+10KB C>T MUTATION. PULMONOLOGIYA. 71–76.
16.
Amelina, E., et al.. (2013). The impact of genotype on clinical course of cystic fibrosis (CF) in adult patients. European Respiratory Journal. 42(Suppl 57). P1179–P1179. 2 indexed citations
17.
Amelina, E., et al.. (2013). High frequency chest wall oscillation (HFCWO) in the treatment of acute pulmonary exacerbation in adult cystic fibrosis (CF) patients. European Respiratory Journal. 42(Suppl 57). P3599–P3599. 2 indexed citations
18.
Amelina, E., et al.. (2013). Tobramycin inhalations in therapy of chronic infection Pseudomonas aeruginosa in cystic fibrosis. PULMONOLOGIYA. 109–114. 1 indexed citations
19.
Amelina, E., et al.. (2012). Cystic fibrosis and tuberculosis. PULMONOLOGIYA. 34–39. 1 indexed citations
20.
Amelina, E., et al.. (2011). Bone mineral density, vertebral deformities prevalence and bone fractures in adult cystic fibrosis patients. PULMONOLOGIYA. 71–78. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amir Akhavan Rezayat Breakdown of academic impact, for papers by Annette Sauer‐Heilborn Breakdown of academic impact, for papers by Nicole Mayer‐Hamblett Breakdown of academic impact, for papers by Benjamin R. Macadangdang Breakdown of academic impact, for papers by Gökçen Dilşa Tuğcu Breakdown of academic impact, for papers by Samuel Montgomery Breakdown of academic impact, for papers by Howard Todd Breakdown of academic impact, for papers by H. G. de Vries Breakdown of academic impact, for papers by Spyridon Megremis Breakdown of academic impact, for papers by Adelina Amorim
Rankless by CCL
2026